Monday, July 21, 2025
Read the Digital Magazines Subscribe to the Magazines
Subscribe

Life Sciences

Pennovation-Center-Philadelphia
DevelopmentLife SciencesNortheastPennsylvania

Longfellow Real Estate to Undertake $365M Life Sciences Expansion Project at UPenn

by Taylor Williams

PHILADELPHIA — Longfellow Real Estate Partners will undertake a $365 million expansion project at Pennovation Center, a life sciences development located across the Schuylkill River from the University of Pennsylvania in Philadelphia. The university owns the 23-acre site on which the facility will be constructed. The initial, 65,000-square-foot lab opened last year, and the expansion will add 387,000 square feet of research and development space and 68,000 square feet of biomanufacturing space to the local supply. Architectural and engineering firm Jacobs is designing the project, construction of which is scheduled to begin next year, with completion slated for 2025.

Continue Reading
FacebookTwitterLinkedinEmail
One-Patriots-Park-Bedford
AcquisitionsLife SciencesMassachusettsNortheast

Newmark Brokers $132M Sale of Life Sciences Complex in Bedford, Massachusetts

by Taylor Williams

BEDFORD, MASS. — Newmark has brokered the $132 million sale of One Patriots Park, a 143,553-square-foot life sciences complex in Bedford, a northwestern suburb of Boston. The seller, Jumbo Capital Inc., redeveloped the property in 2019 to support life sciences users. At the time of sale, four such tenants — Homology Medicines Inc., N2 Biomedical, Frontera Therapeutics and Obsidian Therapeutic — occupied the entirety of the facility. Robert Griffin, Edward Maher, Matthew Pullen and Samantha Hallowell of Newmark represented Jumbo Capital and procured the buyer, Barings, in the transaction.

Continue Reading
FacebookTwitterLinkedinEmail
Warren-Corporate-Center
Leasing ActivityLife SciencesNew JerseyNortheast

PTC Therapeutics Signs 360,000 SF Life Sciences Lease in Northern New Jersey

by Taylor Williams

WARREN, N.J. — PTC Therapeutics has signed a 360,000-square-foot life sciences lease at Warren Corporate Center in Northern New Jersey. Originally built as the headquarters campus for Lucent Technologies, the 176-acre Warren Corporate Center comprises five buildings totaling 820,000 square feet, and construction on the new facility for PTC Therapeutics will begin this month. Jeff Zell and Louis Kluger of JM Zell Partners represented the tenant in the lease negotiations. Robert Donnelly Sr., Robert Donnelly Jr., Paul Giannone, Todd Elfand and Kevin Carton of Cushman & Wakefield represented the landlord, a joint venture between Rubenstein Partners and Vision Real Estate Partners.

Continue Reading
FacebookTwitterLinkedinEmail
451-D-Street-aerial
AcquisitionsLife SciencesMassachusettsNortheastOfficeTop Stories

GI Partners Acquires 479,000 SF Life Sciences Property in Boston’s Seaport District

by Katie Sloan

BOSTON — GI Partners has acquired 451 D Street, a state-of-the-art life sciences, data center and creative office building in Boston’s Seaport District. The price was not disclosed, but the seller, Related Fund Management, bought the asset for $276 million in 2018, according to reports by the Boston Business Journal. The nine-story, 479,000-square-foot building recently underwent two phases of lab conversion that total over half of the building’s rentable area. The property offers 536 parking spaces; a conference center; amenity center with a lounge, kitchen and games; an onsite cafe; bicycle storage; and a 3,000-square-foot fitness center.  Current tenants include AT&T, J.P.Morgan, Silicon Therapeutics, Elektrofi, BT, Inozyme Pharma, Cellink, Stevanato Group Pharmaceutical Systems, Joyn Bio, Sensei Biotherapeutics, DermBoint and Dewpoint Therapeutics.  Related will maintain a minority interest in the property and Related Beal will continue to serve as property manager. Eastdil Secured represented the seller in the transaction and placed debt financing for the new ownership group. “The Seaport has become a bona fide life sciences innovation hub and 451 D exemplifies our focus on serving the needs of small and medium-sized lab tenants through Class A reusable buildouts,” says John Sheputis, managing director at GI Partners and head of acquisitions for …

Continue Reading
FacebookTwitterLinkedinEmail
DevelopmentIllinoisLife SciencesMidwest

Skender Completes Construction of 54,000 SF Lab, Office Buildout for Hazel Technologies in Chicago

by Kristin Harlow

CHICAGO — Skender has completed construction of a two-story, 54,000-square-foot lab and office buildout for Hazel Technologies at 320 N. Sangamon St. in Chicago’s Fulton Market. Hazel is a USDA-funded technology company that develops solutions to extend the shelf life of fresh produce. The company is one of the first tenants to move into the new 13-story office building developed by Tishman Speyer and Mark Goodman & Associates. Hazel is moving from its current location at University Technology Park at Illinois Tech and plans to double its local workforce to approximately 100 employees this year. The buildout includes space for open research laboratory and lab support, 10,000 square feet of administrative and office space and 5,000 square feet of collaboration space. The project team included architect Perkins & Will, engineer Cosentini Associates and tenant representative CBRE.

Continue Reading
FacebookTwitterLinkedinEmail
DevelopmentIllinoisLife SciencesMidwest

Trammell Crow Co. to Open Spec Suites at Chicago’s Fulton Labs in August

by Kristin Harlow

CHICAGO — Trammell Crow Co. (TCC) is set to open its Science Ready Lab Suites at Fulton Labs, a life sciences development in Chicago. These fully built out, move-in ready spaces span 3,000 to 7,000 square feet and provide advanced research and development space. Celadyne Technologies Inc. has signed a lease as the first tenant to occupy the Science Ready Lab Suites. The suites, which are available for occupancy beginning in August, will provide tenants with flexible lease terms and access to a shared lab equipment room. Fulton Labs is a two-building life sciences campus from TCC that spans 725,000 square feet. Jonathan Metzl of Cushman & Wakefield represented Celadyne Technologies in its lease.

Continue Reading
FacebookTwitterLinkedinEmail
777-Industrial-Road-San-Carlos-CA
CaliforniaDevelopmentIndustrialLife SciencesWestern

Presidio Bay Ventures Breaks Ground on 147,000 SF Life Sciences Project in San Carlos, California

by Amy Works

SAN CARLOS, CALIF. — Presidio Bay Ventures has broken ground on a Class A life sciences and R&D development located at 777 Industrial Road in San Carlos. The existing 45,000-square-foot dealership building will be fully redeveloped into a four-story, 147,000-square-foot, state-of-the-art facility. Stanton Architecture and DES Architects & Engineers designed the building, which will be tailored toward research and development users with a heavy lab component. Potential tenants include companies working in life sciences, biotech, food tech, agricultural tech, auto tech, drone tech, robotics, and other users requiring mission-critical infrastructure. Building amenities will include e-bikes, outdoor workspaces equipped with Wi-Fi and an onsite fitness center. Approved in June 2021, the project is slated for completion in fourth-quarter 2023. Marc Pope and Ben Paul of Cushman & Wakefield are handling leasing for the building.

Continue Reading
FacebookTwitterLinkedinEmail
500-White-Plains-Road-Tarrytown
AcquisitionsLife SciencesNew YorkNortheast

CBRE Negotiates $26M Sale-Leaseback of Life Sciences Complex in Tarrytown, New York

by Taylor Williams

TARRYTOWN, N.Y. — CBRE has negotiated the $26 million sale-leaseback of a 276,000-square-foot life sciences complex located in Tarrytown, a northern suburb of New York City. Jeffrey Dunne, Steven Bardsley, Travis Langer, Alyssa Fricke, David Opper and Jeff Babikian of CBRE represented the seller, BASF Corp., which will lease back a portion of the space at the two-building complex. CBRE also procured the buyer, an affiliate of Northpath Investments. The property was 52 percent leased at the time of sale, inclusive of BASF’s occupancy and a separate lease with Northwell Health System. Michael Klein and Max Custer of JLL arranged acquisition financing through Prime Finance for the deal.

Continue Reading
FacebookTwitterLinkedinEmail
DevelopmentLife SciencesMassachusettsNortheast

Berkeley Investments to Develop 200,000 SF Life Sciences Facility in Billerica, Massachusetts

by Taylor Williams

BILLERICA, MASS. — Boston-based Berkeley Investments will develop Billerica Crossing, a 200,000-square-foot life sciences facility that will be located north of the state capital. Brian Morrissey, Michael Restivo, Martha Nay, Lenny Pierce and David Coffman of JLL represented Boston-based Cabot Corp. in its sale of the 18-acre tract to Berkeley Investments. Cabot owns and operates a research and development facility on the adjacent parcel. A construction timeline was not disclosed.

Continue Reading
FacebookTwitterLinkedinEmail
DevelopmentLife SciencesMassachusettsNortheast

Anchor Line, Northwood Top Out 215,000 SF Life Sciences Building Near Boston

by Taylor Williams

CAMBRIDGE, MASS. — A partnership between Boston-based developer Anchor Line Partners and international asset management firm Northwood Investors has topped out 60 First Street, a 215,000-square-foot life sciences project located across the Charles River from Boston in Cambridge. The five-story property, which is a redevelopment of the former Sears building, includes ground-floor retail space and has been fully preleased. Biotech startup Prime Medicine has committed to 148,000 square feet across three floors, and RNA editing company Korro Bio has leased 50,000 square feet across two floors. Full completion of the project is slated for early 2023.

Continue Reading
FacebookTwitterLinkedinEmail
Newer Posts
Older Posts